Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Chipseq and statistical models

    I was wondering a bit about the statistical models used by peak-calling software and how they compare to the models normally employed by packages designed for RNAseq. It's my understanding that most RNAseq tools for differential expression analysis. The way I understand a negative binomial distribution is that it's a lot like a Poisson distribution, except that a negative binomial distribution takes into account the fact that the mean/variance won't be equal across biological replicates.

    From what I've read, some Chipseq tools use the negative binomial distribution, while others use the Hidden Markov Model (HMM). I read the wikipedia entry on HMM and found it... less than clear. The way I understand it, a Markov model refers to a series of discrete "states", where each state depends upon the previous state in a non-deterministic way. So, for example, a tree might be classified as "small", "medium" or "large". That tree has to go through the "medium" state before it can reach the "large" state, but just because a tree is "medium" doesn't mean it will ever become "large". The size of the tree is related to how rainy it was on a previous year, so if it was exceptionally rainy, there might be a 70% chance that the tree you observe will be large. When refering to a Hidden Markov Model, you refer to a Markov chain in which some of the states are hidden, or unobserved. So to use the tree example, if you didn't have the weather data for the previous year, you'd have to infer how rainy it was based upon how many "large" trees you observe.

    Assuming that understanding isn't completely wrong, I don't really see how it applies to Chipseq. Can someone explain to me why this model is used in Chipseq analysis, and why some tools use negative binomial distribution instead?
    Last edited by Rivalyn; 05-27-2014, 05:50 AM.

Latest Articles

Collapse

  • seqadmin
    Advancing Precision Medicine for Rare Diseases in Children
    by seqadmin




    Many organizations study rare diseases, but few have a mission as impactful as Rady Children’s Institute for Genomic Medicine (RCIGM). “We are all about changing outcomes for children,” explained Dr. Stephen Kingsmore, President and CEO of the group. The institute’s initial goal was to provide rapid diagnoses for critically ill children and shorten their diagnostic odyssey, a term used to describe the long and arduous process it takes patients to obtain an accurate...
    12-16-2024, 07:57 AM
  • seqadmin
    Recent Advances in Sequencing Technologies
    by seqadmin



    Innovations in next-generation sequencing technologies and techniques are driving more precise and comprehensive exploration of complex biological systems. Current advancements include improved accessibility for long-read sequencing and significant progress in single-cell and 3D genomics. This article explores some of the most impactful developments in the field over the past year.

    Long-Read Sequencing
    Long-read sequencing has seen remarkable advancements,...
    12-02-2024, 01:49 PM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by seqadmin, 12-17-2024, 10:28 AM
0 responses
26 views
0 likes
Last Post seqadmin  
Started by seqadmin, 12-13-2024, 08:24 AM
0 responses
43 views
0 likes
Last Post seqadmin  
Started by seqadmin, 12-12-2024, 07:41 AM
0 responses
29 views
0 likes
Last Post seqadmin  
Started by seqadmin, 12-11-2024, 07:45 AM
0 responses
42 views
0 likes
Last Post seqadmin  
Working...
X